Related Experiment Video
Updated: Aug 3, 2026

Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages
Tetsuji Nakano1, Kazufumi Hiramatsu, Kenji Kishi
1Second Department of Internal Medicine, Oita Medical University, Hasama, Oita 879-5593, Japan.
Abstract:
We investigated the mechanism by which clindamycin (CLI) modulates cytokine induction after lipopolysaccharide (LPS) stimulation. Although CLI decreased the intracellular expression levels of tumor necrosis factor alpha and interleukin 1beta (IL-1beta) and increased IL-6 expression in macrophages, cytokine mRNA expression levels were similar in CLI-treated and untreated groups. Our findings suggest that CLI modulates cytokine production in LPS-stimulated macrophages.
Insights
Clindamycin (CLI) affects cytokine production in macrophages stimulated with lipopolysaccharide (LPS). While intracellular levels of certain cytokines change, their mRNA levels remain unaffected, suggesting post-transcriptional modulation by CLI.
Area of Science:
- Immunology
- Pharmacology
Background:
- Lipopolysaccharide (LPS) is a potent stimulator of immune responses in macrophages.
- Cytokine induction is a critical component of the inflammatory process.
- Understanding how antibiotics modulate these responses is crucial for clinical applications.
Purpose of the Study:
- To investigate the mechanism by which clindamycin (CLI) modulates cytokine induction.
- To determine the effect of CLI on intracellular cytokine expression and mRNA levels following LPS stimulation.
Main Methods:
- Macrophage cell cultures were stimulated with LPS.
- Clindamycin (CLI) was administered to investigate its modulatory effects.
- Intracellular cytokine expression levels (TNF-alpha, IL-1beta, IL-6) were measured.
- Cytokine mRNA expression levels were quantified.
Main Results:
- CLI decreased intracellular expression of tumor necrosis factor alpha and interleukin-1beta.
- CLI increased intracellular expression of interleukin-6.
- No significant differences in cytokine mRNA expression levels were observed between CLI-treated and untreated groups.
Conclusions:
- Clindamycin modulates intracellular cytokine production in LPS-stimulated macrophages.
- The mechanism of modulation appears to occur post-transcriptionally.
- These findings highlight a potential immunomodulatory role of clindamycin beyond its antimicrobial activity.

